ScoreWhy is Shandong Wit Dyne Health Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 0.53% and Operating profit at 7.21% over the last 5 years
2
Negative results in Mar 26
- NET PROFIT(HY) At CNY 235.72 MM has Grown at -27.55%
- ROCE(HY) Lowest at 15.28%
- NET SALES(Q) Lowest at CNY 412.27 MM
3
With ROE of 29.85%, it has a fair valuation with a 2.10 Price to Book Value
- Over the past year, while the stock has generated a return of -23.78%, its profits have fallen by -13.4%
- At the current price, the company has a high dividend yield of 9.4
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -23.78% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Shandong Wit Dyne Health Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shandong Wit Dyne Health Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Shandong Wit Dyne Health Co., Ltd.
-24.07%
-0.93
23.60%
China Shanghai Composite
3.23%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.53%
EBIT Growth (5y)
7.21%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-1.01
Sales to Capital Employed (avg)
0.78
Tax Ratio
14.79%
Dividend Payout Ratio
109.41%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
445.46%
ROE (avg)
33.88%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
7
Industry P/E
Price to Book Value
2.13
EV to EBIT
3.13
EV to EBITDA
2.95
EV to Capital Employed
-10.53
EV to Sales
1.51
PEG Ratio
NA
Dividend Yield
1.85%
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
29.85%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-23What is not working for the Company
NET PROFIT(HY)
At CNY 219.88 MM has Grown at -34.01%
OPERATING CASH FLOW(Y)
Lowest at CNY 538.79 MM
ROCE(HY)
Lowest at 15.6%
NET SALES(Q)
At CNY 436.08 MM has Fallen at -13.83%
DEBT-EQUITY RATIO
(HY)
Highest at -84.29 %
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.41 times
Here's what is not working for Shandong Wit Dyne Health Co., Ltd.
Net Profit
At CNY 219.88 MM has Grown at -34.01%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Net Sales
At CNY 436.08 MM has Fallen at -13.83%
over average net sales of the previous four periods of CNY 506.09 MMMOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Operating Cash Flow
Lowest at CNY 538.79 MM
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (CNY MM)
Debt-Equity Ratio
Highest at -84.29 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio
Lowest at 5.41 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Non Operating Income
Highest at CNY 0.14 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
